Gold futures moved in a range yesterday after Pfizer and BioNTech disclosed positive final-analysis data from a trial of their coronavirus vaccine. COMEX Gold pulled back near $1860 per ounce. The metal currently trades down 0.47% at $1864 per ouncw.
Gold fell on Thursday in early Asian trade as the dollar gained some ground and progress in COVID-19 vaccine development dented the precious metal’s appeal. Spot gold fell 0.1% to $1,869.86 per ounce while U.S. gold futures were down 0.3% at $1,868.70. After falling for five straight sessions, the dollar index was up 0.2%, making gold expensive for holders of other currencies. Pfizer announced on Wednesday that the final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective. President-elect Joe Biden expressed hope on Wednesday that Republicans in the U.S. Congress would be more inclined to move forward on COVID-19 relief legislation after President Donald Trump leaves office in January. The U.S. economy is now affected more by swings in COVID-19 infections than it is by restrictions on certain activities, and a surge in cases could slow growth, New York Federal Reserve Bank President John Williams said on Wednesday. Britain and the European Union are in the last moments to reach a trade deal that would regulate their relationship after Britain’s transition period ends on Jan 1, 2021, the EU’s Trade Commissioner Valdis Dombrovskis said on Wednesday. Holdings in SPDR Gold Trust, the world’s largest gold-backed exchange-traded fund, fell 0.60% to 1,219.00 tonnes on Wednesday. Silver fell 0.3 % to $24.24 per ounce.
TREND : BEARISH
Time : 19/11/2020
Pivot : 1871.32
Technical View : LONG ABOVE 1875.65
Target : 1879.98, 1892.91, 1900.98
Technical View : SHORT BELOW 1864.95
Target : 1858.58, 1850.61, 1850.61, 1837.58